UMB Bank n.a. Acquires 1,637 Shares of CME Group Inc. (NASDAQ:CME)

UMB Bank n.a. increased its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 2.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 73,283 shares of the financial services provider's stock after purchasing an additional 1,637 shares during the quarter. UMB Bank n.a.'s holdings in CME Group were worth $19,441,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the company. Lake Street Advisors Group LLC increased its stake in CME Group by 108.7% in the 4th quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider's stock worth $2,949,000 after acquiring an additional 6,453 shares during the last quarter. Unified Investment Management purchased a new stake in CME Group during the 4th quarter valued at $503,000. Aspire Growth Partners LLC bought a new position in CME Group during the 4th quarter valued at approximately $548,000. Massachusetts Financial Services Co. MA increased its position in CME Group by 18.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,169,999 shares of the financial services provider's stock valued at $503,939,000 after purchasing an additional 343,498 shares during the period. Finally, Sentinel Trust Co. LBA purchased a new stake in CME Group in the fourth quarter worth about $368,000. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Trading Down 0.2%

Shares of CME Group stock opened at $274.24 on Friday. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $290.79. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a 50-day moving average of $271.69 and a two-hundred day moving average of $253.09. The stock has a market cap of $98.82 billion, a PE ratio of 28.36, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The company's quarterly revenue was up 10.4% on a year-over-year basis. During the same period last year, the company earned $2.50 earnings per share. On average, research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be given a $1.25 dividend. The ex-dividend date is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.82%. CME Group's payout ratio is currently 50.30%.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. JPMorgan Chase & Co. cut their price target on CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research note on Thursday, April 24th. Royal Bank of Canada reiterated a "sector perform" rating and set a $269.00 target price on shares of CME Group in a research report on Thursday, April 3rd. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a report on Monday, March 10th. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research note on Thursday, April 24th. Finally, Bank of America upped their price objective on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, CME Group currently has an average rating of "Hold" and a consensus price target of $258.20.

Insider Activity

In related news, Director Daniel G. Kaye sold 500 shares of the stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the sale, the director now directly owns 3,668 shares of the company's stock, valued at $1,035,916.56. This represents a 12.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Howard J. Siegel sold 10,000 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the sale, the director now owns 21,873 shares of the company's stock, valued at approximately $5,686,980. This trade represents a 31.37% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 22,900 shares of company stock valued at $6,147,935. 0.30% of the stock is currently owned by insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.